@whytee as you have not yet grasped the difference between
- supposed MSB failure of clinical trials (not the case),
- supposed MSB refusal to comply with reasonable FDA directions (not the case); and
- MSBs catering to the FDA's ever changing needs (with assay consistency not really needed but an FDA quirk to suddenly desire this)
....well, I don't think you're in a position to pronounce on who is a useful idiot or not.
Ok well count yourself out of the useful bit of that category in any case...
Ann: Trading Halt, page-246
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.065(4.73%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.46 | $1.38 | $4.077M | 2.888M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 11814 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 18125 | 14 |
View Market Depth
| Last trade - 13.38pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |